ArticleCell and tissue research2026
Meckel's cartilage midsegment: spatiotemporal dynamics and osteogenic role in mice.
Article in Cell and tissue research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Meckel's cartilage is a transient yet essential structure in the development of the mammalian mandible, with its midsegment undergoing distinct degradation and potentially contributing to bone formation. However, the mechanisms regulating its fate remain unclear. This study aimed to investigate the spatiotemporal changes and potential osteogenic function of the midsegment of Meckel's cartilage during mouse mandibular development. Using C57BL/6 J mice and a tamoxifen-inducible cartilage-specific lineage tracing model, we conducted morphological staining (Alcian Blue, Safranin O, Masson's trichrome) and immunofluorescence analyses targeting key transcription factors (Sox9, Runx2, Osterix) and vascular marker CD31 from embryonic day 12.5 to postnatal day 0. The anterior portion of the midsegment displayed endochondral-like ossification, marked by chondrocyte hypertrophy, matrix remodeling, and subsequent osteogenic invasion. A shift from cell proliferation to differentiation was noted as Ki67-positive cells decreased by embryonic day 14.5. Sequential expression of Sox9, Runx2, and Osterix was observed along the chondrocyte maturation axis, with peripheral localization of Osterix-expressing cells in remodeling zones. Endothelial cells expressing CD31 were closely associated with osteoprogenitor cells co-expressing Runx2 or Osterix, particularly on the incisor-facing side, indicating a spatial relationship between vascular structures and osteogenic differentiation. These findings demonstrate that the midsegment of Meckel's cartilage undergoes an endochondral-like ossification process similar to long bones, involving a Sox9 → Runx2 → Osterix transcriptional cascade and vascular invasion. Thus, our study provides novel evidence of the dynamic ossification of Meckel's cartilage midsegment, clarifying its role in mandibular development and contributing to the long-standing debate on its evolutionary and developmental significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.